These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1901614)

  • 1. Serum CD4, CD8, and interleukin-2 receptor levels in childhood acute myeloid leukemia.
    Pui CH; Schell MJ; Vodian MA; Kline S; Mirro J; Crist WM; Behm FG
    Leukemia; 1991 Mar; 5(3):249-54. PubMed ID: 1901614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia.
    Moon Y; Kim Y; Kim M; Lim J; Kang CS; Kim WI; Shim SI; Chung NG; Park YH; Min WS; Han K
    Ann Clin Lab Sci; 2004; 34(4):410-5. PubMed ID: 15648782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
    Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
    Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].
    Vormoor J; Ritter J; Creutzig U; Schellong G
    Klin Padiatr; 1989; 201(4):227-32. PubMed ID: 2674529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.
    Drexler HG; Thiel E; Ludwig WD
    Leukemia; 1993 Apr; 7(4):489-98. PubMed ID: 7681917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells.
    Taga K; Kasahara Y; Yachie A; Miyawaki T; Taniguchi N
    Immunology; 1991 Jan; 72(1):15-9. PubMed ID: 1900055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
    Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
    Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells.
    Vinante F; Rigo A; Vincenzi C; Ricetti MM; Marrocchella R; Chilosi M; Cassatella MA; Bonazzi L; Pizzolo G
    Leukemia; 1993 Oct; 7(10):1552-6. PubMed ID: 8412317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
    Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
    Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
    Marcante R; Cavedon G
    Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on interleukin-2 receptor genes in acute myeloid leukemia cells].
    Yang Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):288-92. PubMed ID: 10684036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts.
    Pizzolo G; Rigo A; Zanotti R; Vinante F; Vincenzi C; Cassatella M; Carra G; Castaman G; Chilosi M; Semenzato G
    Leukemia; 1993 Mar; 7(3):418-25. PubMed ID: 8445947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haematological characteristics, FAB and WHO classification of 153 cases of myeloid acute leukaemia in Tunisia].
    Braham-Jmili N; Sendi-Senana H; Labiadh S; Ben Abdelali R; Ben Abdelaziz A; Khelif A; Saad A; Kortas M
    Ann Biol Clin (Paris); 2006; 64(5):457-65. PubMed ID: 17040877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical importance of interleukin-2 receptor alpha-chain expression in acute leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
    Nakase K; Kita K; Kageyama S; Tsuji K; Miyanishi E; Miwa H; Tanaka I; Shirakawa S; Tanaka I; Anazawa H; Tsutani H; Kyo T; Dohy H; Kamada N; Doi S; Nasu K; Uchino H
    Cancer Detect Prev; 1997; 21(3):273-9. PubMed ID: 9167045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.